ISIN | CH0104078727 |
---|---|
Valor Number | 10407872 |
Bloomberg Global ID | |
Fund Name | Schroder Swiss Equity Core Fund I |
Fund Provider |
Schroder Investment Management (Switzerland) AG (LUX & CH)
Zurich/Geneva, Switzerland Web: https://www.schroders.com/en/ch/asset-management/ Phone: +41 (0) 800 844 448 E-Mail: info-sim@schroders.com |
Fund Provider | Schroder Investment Management (Switzerland) AG (LUX & CH) |
Representative in Switzerland | |
Distributor(s) |
Schroder & Co Bank AG Zürich Phone: +41 44 250 11 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Schroder Swiss Equity Core Fund is an open-end fund incorporated in Switzerland. The Fund's objective is to obtain long-term capital growth. The Fund is actively managed and tries to exceeds the performance of Swiss Performance Index (SPI). |
Peculiarities |
Current Price * | 284.62 CHF | 15.09.2025 |
---|---|---|
Previous Price * | 285.22 CHF | 12.09.2025 |
52 Week High * | 294.33 CHF | 03.03.2025 |
52 Week Low * | 245.51 CHF | 09.04.2025 |
NAV * | 284.62 CHF | 15.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 16,759,527 | |
Unit/Share Assets *** | 14,897,442 | |
Trading Information SIX |
YTD Performance | +8.64% |
30.12.2024 - 15.09.2025
30.12.2024 15.09.2025 |
---|---|---|
1 month | +0.63% |
15.08.2025 - 15.09.2025
15.08.2025 15.09.2025 |
3 months | +0.95% |
16.06.2025 - 15.09.2025
16.06.2025 15.09.2025 |
6 months | -2.21% |
17.03.2025 - 15.09.2025
17.03.2025 15.09.2025 |
1 year | +5.02% |
16.09.2024 - 15.09.2025
16.09.2024 15.09.2025 |
2 years | +13.94% |
15.09.2023 - 15.09.2025
15.09.2023 15.09.2025 |
3 years | +23.17% |
15.09.2022 - 15.09.2025
15.09.2022 15.09.2025 |
5 years | +29.30% |
15.09.2020 - 15.09.2025
15.09.2020 15.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.07% | |
---|---|---|
Roche Holding AG | 11.11% | |
Nestle SA | 10.77% | |
Compagnie Financiere Richemont SA Class A | 5.21% | |
Zurich Insurance Group AG | 5.09% | |
UBS Group AG Registered Shares | 3.95% | |
ABB Ltd | 3.20% | |
Sandoz Group AG Registered Shares | 3.19% | |
Partners Group Holding AG | 2.72% | |
Galderma Group AG Registered Shares | 2.58% | |
Last data update | 31.08.2025 |
TER | 0.09% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.09% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |